Morrison & Foerster's (MoFo) London office has landed a role advising biotech company CellCentric on its $200m (£134m) out-licensing of a research programme focusing on cancer. CellCentric has out-licensed the development and commercialisation of the programme to Japanese drugs firm Takeda Pharmaceutical Company.
March 30, 2010 at 02:40 AM
1 minute read
The original version of this story was published on Legalweek
Morrison & Foerster’s (MoFo) London office has landed a role advising biotech company CellCentric on its $200m (£134m) out-licensing of a research programme focusing on cancer.
CellCentric has out-licensed the development and commercialisation of the programme to Japanese drugs firm Takeda Pharmaceutical Company.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Duane Morris LLP seeks a highly motivated junior associate to join its dynamic and growing Labor and Employment Class Action group in Chicag...
Duane Morris LLP seeks a full-time staff litigation attorney who has practiced between 3-5 years. Experience will include drafting motions, ...
Duane Morris LLP has an immediate opening for a senior level, highly motivated litigation associate to join its dynamic and growing Employme...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
